妇科手术后盆腹腔粘连预防及诊断的专家共识(2020年版)

2020-06-15 中国研究型医院学会 中国微创外科杂志.2020.20(6):481-488.

妇科手术后盆腹腔粘连是指手术组织/部位损伤后,在组织愈合过程中发生的一系列病理生理过程和结局,粘连所致的疾病包括女性不孕/不育、肠粘连/梗阻、慢性腹痛/盆腔痛等多种并发症,并增加盆腹腔再次手术的操作难

中文标题:

妇科手术后盆腹腔粘连预防及诊断的专家共识(2020年版)

发布机构:

中国研究型医院学会

发布日期:

2020-06-15

简要介绍:

妇科手术后盆腹腔粘连是指手术组织/部位损伤后,在组织愈合过程中发生的一系列病理生理过程和结局,粘连所致的疾病包括女性不孕/不育、肠粘连/梗阻、慢性腹痛/盆腔痛等多种并发症,并增加盆腹腔再次手术的操作难度。中国研究型医院学会妇产科专业委员会组织有关专家制定本共识,通过分析妇科手术后盆腹腔粘连发生的流行病学特点、粘连形成机制和相关的临床结局,总结盆腹腔粘连风险的评估系统。本共识遵循循证医学理念,对有关治疗或干预方案给出循证评价,以期综合评估有关降低妇科手术术后粘连形成的各种方法的有效性,进一步规范我国妇科手术后盆腹腔粘连预防的临床规范。

相关资料下载:
[AttachmentFileName(sort=1, fileName=妇科手术后盆腹腔粘连预防及诊断的专家共识_2020年版_徐帅.pdf)] GetToolGuiderByIdResponse(projectId=1, id=116621c001926327, title=妇科手术后盆腹腔粘连预防及诊断的专家共识(2020年版), enTitle=, guiderFrom=中国微创外科杂志.2020.20(6):481-488., authorId=0, author=, summary=妇科手术后盆腹腔粘连是指手术组织/部位损伤后,在组织愈合过程中发生的一系列病理生理过程和结局,粘连所致的疾病包括女性不孕/不育、肠粘连/梗阻、慢性腹痛/盆腔痛等多种并发症,并增加盆腹腔再次手术的操作难, cover=https://img.medsci.cn/2020626/1593184786630_2020535.jpg, journalId=0, articlesId=null, associationId=1023, associationName=中国研究型医院学会, associationIntro=中国研究型医院学会,英文名称Chinese Research Hospital Association(CRHA),是经国家民政部正式批复并登记注册的全国性一级学会,是独立的法人社团。中国研究型医院学会是由以探索和建设研究型医院为目标的具有医疗服务、科学研究和临床教学&ldquo;三位一体&rdquo;功能的医疗机构,以及从事研究型医院理论与实践研究的人员自愿结成的全国性、专业性、学术性、非营利性社会组织。, copyright=0, guiderPublishedTime=Mon Jun 15 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>妇科手术后盆腹腔粘连是指手术组织/部位损伤后,在组织愈合过程中发生的一系列病理生理过程和结局,粘连所致的疾病包括女性不孕/不育、肠粘连/梗阻、慢性腹痛/盆腔痛等多种并发症,并增加盆腹腔再次手术的操作难度。中国研究型医院学会妇产科专业委员会组织有关专家制定本共识,通过分析妇科手术后盆腹腔粘连发生的流行病学特点、粘连形成机制和相关的临床结局,总结盆腹腔粘连风险的评估系统。本共识遵循循证医学理念,对有关治疗或干预方案给出循证评价,以期综合评估有关降低妇科手术术后粘连形成的各种方法的有效性,进一步规范我国妇科手术后盆腹腔粘连预防的临床规范。</p> </div> </div> </div>, tagList=[TagDto(tagId=56538, tagName=妇科手术), TagDto(tagId=104566, tagName=盆腹腔粘)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=56538, guiderKeyword=妇科手术, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3347, appHits=314, showAppHits=0, pcHits=779, showPcHits=3033, likes=1, shares=21, comments=7, approvalStatus=1, publishedTime=Fri Jun 26 23:56:22 CST 2020, publishedTimeString=2020-06-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Jun 26 23:19:50 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 10:32:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=妇科手术后盆腹腔粘连预防及诊断的专家共识_2020年版_徐帅.pdf)])
妇科手术后盆腹腔粘连预防及诊断的专家共识_2020年版_徐帅.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1203084, encodeId=f41912030844a, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201207/c90e91ef40764236aed29bf0de055c37/23caad74c24d4fc2b36ce99b11a0323d.jpg, createdBy=dbd41665725, createdName=哈!, createdTime=Wed Mar 16 13:04:17 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196717, encodeId=73e51196e176c, content=在临床中很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07b4149549, createdName=13c82a4bm11暂无昵称, createdTime=Thu Feb 24 09:48:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183428, encodeId=a9e5118342854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Jan 12 08:21:32 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056015, encodeId=cd76105601516, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=788c5620299, createdName=ms8000000034887809, createdTime=Wed Sep 29 12:09:32 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880816, encodeId=658a88081602, content=学习了,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Aug 30 09:51:44 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2022-03-16 哈!

    收益很多

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1203084, encodeId=f41912030844a, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201207/c90e91ef40764236aed29bf0de055c37/23caad74c24d4fc2b36ce99b11a0323d.jpg, createdBy=dbd41665725, createdName=哈!, createdTime=Wed Mar 16 13:04:17 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196717, encodeId=73e51196e176c, content=在临床中很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07b4149549, createdName=13c82a4bm11暂无昵称, createdTime=Thu Feb 24 09:48:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183428, encodeId=a9e5118342854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Jan 12 08:21:32 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056015, encodeId=cd76105601516, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=788c5620299, createdName=ms8000000034887809, createdTime=Wed Sep 29 12:09:32 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880816, encodeId=658a88081602, content=学习了,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Aug 30 09:51:44 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2022-02-24 13c82a4bm11暂无昵称

    在临床中很实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1203084, encodeId=f41912030844a, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201207/c90e91ef40764236aed29bf0de055c37/23caad74c24d4fc2b36ce99b11a0323d.jpg, createdBy=dbd41665725, createdName=哈!, createdTime=Wed Mar 16 13:04:17 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196717, encodeId=73e51196e176c, content=在临床中很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07b4149549, createdName=13c82a4bm11暂无昵称, createdTime=Thu Feb 24 09:48:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183428, encodeId=a9e5118342854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Jan 12 08:21:32 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056015, encodeId=cd76105601516, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=788c5620299, createdName=ms8000000034887809, createdTime=Wed Sep 29 12:09:32 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880816, encodeId=658a88081602, content=学习了,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Aug 30 09:51:44 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2022-01-12 D-House

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1203084, encodeId=f41912030844a, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201207/c90e91ef40764236aed29bf0de055c37/23caad74c24d4fc2b36ce99b11a0323d.jpg, createdBy=dbd41665725, createdName=哈!, createdTime=Wed Mar 16 13:04:17 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196717, encodeId=73e51196e176c, content=在临床中很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07b4149549, createdName=13c82a4bm11暂无昵称, createdTime=Thu Feb 24 09:48:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183428, encodeId=a9e5118342854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Jan 12 08:21:32 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056015, encodeId=cd76105601516, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=788c5620299, createdName=ms8000000034887809, createdTime=Wed Sep 29 12:09:32 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880816, encodeId=658a88081602, content=学习了,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Aug 30 09:51:44 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2021-09-29 ms8000000034887809

    加油

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1203084, encodeId=f41912030844a, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201207/c90e91ef40764236aed29bf0de055c37/23caad74c24d4fc2b36ce99b11a0323d.jpg, createdBy=dbd41665725, createdName=哈!, createdTime=Wed Mar 16 13:04:17 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196717, encodeId=73e51196e176c, content=在临床中很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07b4149549, createdName=13c82a4bm11暂无昵称, createdTime=Thu Feb 24 09:48:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183428, encodeId=a9e5118342854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Jan 12 08:21:32 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056015, encodeId=cd76105601516, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=788c5620299, createdName=ms8000000034887809, createdTime=Wed Sep 29 12:09:32 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880816, encodeId=658a88081602, content=学习了,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Aug 30 09:51:44 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2020-08-30 120c570cm03暂无昵称

    学习了,好

    0